SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
3.280
+0.230 (7.54%)
At close: Aug 7, 2026, 4:00 PM EDT
3.450
+0.170 (5.18%)
Pre-market: Aug 10, 2026, 9:00 AM EDT
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $495.00K in the quarter ending March 31, 2026, with 68.94% growth. This brings the company's revenue in the last twelve months to $1.44M, up 235.51% year-over-year. In the year 2025, SeaStar Medical Holding had annual revenue of $1.23M with 814.07% growth.
Revenue (ttm)
$1.44M
Revenue Growth
+235.51%
P/S Ratio
9.18
Revenue / Employee
$84,471
Employees
17
Market Cap
13.19M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23M | 1.10M | 814.07% |
| Dec 31, 2024 | 135.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ICU News
- 4 days ago - SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026 - GlobeNewsWire
- 27 days ago - SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI) - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Holding Transcript: Investor Summit Virtual Conference - Transcripts
- 6 weeks ago - SeaStar Medical announces new CD-10-PCS codes for SCD therapy - TheFly
- 6 weeks ago - SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury - GlobeNewsWire
- 7 weeks ago - SeaStar Medical to Present at Upcoming Investor Summit Conference - GlobeNewsWire
- 3 months ago - SeaStar Medical price target raised to $8 from $6 at Maxim - TheFly
- 3 months ago - SeaStar Medical Holding Earnings Call Transcript: Q1 2026 - Transcripts